[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1079661A1 - Use of lactobacillus reuteri strains for preparingcomposition of improving immune function in mammals - Google Patents

Use of lactobacillus reuteri strains for preparingcomposition of improving immune function in mammals

Info

Publication number
HK1079661A1
HK1079661A1 HK05111951A HK05111951A HK1079661A1 HK 1079661 A1 HK1079661 A1 HK 1079661A1 HK 05111951 A HK05111951 A HK 05111951A HK 05111951 A HK05111951 A HK 05111951A HK 1079661 A1 HK1079661 A1 HK 1079661A1
Authority
HK
Hong Kong
Prior art keywords
lactobacillus reuteri
mammals
strains
preparingcomposition
immune function
Prior art date
Application number
HK05111951A
Other languages
English (en)
Inventor
Kang Ho-Jin
Kwon Ik-Boo
Connolly Eamonn
Moillstam Bo
Lee Dong-Seong
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of HK1079661A1 publication Critical patent/HK1079661A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
HK05111951A 2002-10-18 2005-12-23 Use of lactobacillus reuteri strains for preparingcomposition of improving immune function in mammals HK1079661A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE2002/001903 WO2004034808A1 (en) 2002-10-18 2002-10-18 Method of improving immune function in mammals using lactobacillus reuteri strains

Publications (1)

Publication Number Publication Date
HK1079661A1 true HK1079661A1 (en) 2006-04-13

Family

ID=32105771

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05111951A HK1079661A1 (en) 2002-10-18 2005-12-23 Use of lactobacillus reuteri strains for preparingcomposition of improving immune function in mammals

Country Status (13)

Country Link
US (1) US20060002907A1 (xx)
EP (1) EP1567018B1 (xx)
JP (1) JP2006506371A (xx)
CN (1) CN100348119C (xx)
AT (1) ATE434940T1 (xx)
AU (1) AU2002347697B2 (xx)
BR (1) BR0215884A (xx)
DE (1) DE60232827D1 (xx)
DK (1) DK1567018T3 (xx)
ES (1) ES2329020T3 (xx)
HK (1) HK1079661A1 (xx)
MX (1) MXPA05003743A (xx)
WO (1) WO2004034808A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
WO2006064449A1 (en) * 2004-12-15 2006-06-22 Van Der Westhuizen Cornelis Fl Detoxifying and immunity-booster composition
US20060251634A1 (en) 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
US7910127B2 (en) * 2007-03-02 2011-03-22 Biogaia Ab Use of lactic acid bacteria for improving food lysine absorption of pet animals
FI121952B (fi) 2009-05-06 2011-06-30 Oriola Oy Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi
US20110293710A1 (en) * 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
EP3145518B1 (en) 2014-05-05 2021-02-17 Probiotical S.p.A. A composition comprising l. reuteri ler03 and l. salivarius ls06 for use in antiviral and antibacterial treating in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy
DK3139940T3 (da) * 2014-05-05 2021-05-17 Probiotical Spa Sammensætning omfattende l. reuteri ler03 og l. salivarius ls06 til anvendelse til behandling af tumorer, aids og leukæmi
CN114269897B (zh) * 2019-09-26 2024-08-02 精密生物集团有限公司 罗伊乳杆菌
WO2022103837A1 (en) * 2020-11-10 2022-05-19 Elanco Us Inc. Immunogenic probiotic compositions and methods of use including in vaccination
CN113073066B (zh) * 2021-04-16 2022-01-04 段云峰 罗伊氏乳杆菌及其应用、组合物、药物和食品
CN113881597B (zh) * 2021-10-15 2023-04-28 江南大学 一株能够提高吲哚丙烯酸以调节特异性IgE的罗伊氏乳杆菌

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2139107A1 (en) * 1992-06-25 1994-01-06 Walter J. Dobrogosz Method of stimulating the immune system
CA2213434C (en) * 1995-12-21 2008-12-09 Abbott Laboratories Use of lactobacillus reuteri to inhibit cryptosporidiosis in mammals
DE29724816U1 (de) * 1997-01-09 2004-07-22 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter

Also Published As

Publication number Publication date
ATE434940T1 (de) 2009-07-15
CN1668211A (zh) 2005-09-14
CN100348119C (zh) 2007-11-14
DE60232827D1 (de) 2009-08-13
AU2002347697B2 (en) 2008-03-20
JP2006506371A (ja) 2006-02-23
WO2004034808A1 (en) 2004-04-29
ES2329020T3 (es) 2009-11-20
MXPA05003743A (es) 2005-06-17
DK1567018T3 (da) 2009-09-14
BR0215884A (pt) 2005-12-20
EP1567018B1 (en) 2009-07-01
AU2002347697A1 (en) 2004-05-04
US20060002907A1 (en) 2006-01-05
EP1567018A1 (en) 2005-08-31

Similar Documents

Publication Publication Date Title
HK1079661A1 (en) Use of lactobacillus reuteri strains for preparingcomposition of improving immune function in mammals
DK1789531T3 (da) Lactobacillus rhamnosus med kropsfedt-mindskende aktivitet og fødevarer indeholdende dem
AU2013205271B2 (en) Human CGRP receptor binding proteins
MX2007002528A (es) Lactobacillus plantarum con actividad reductora de grasa corporal y los alimentos que lo contienen.
SG155947A1 (en) Compositions and methods for the diagnosis and treatment of tumor
MX2008007286A (es) Ingenieria in vivo de superficie celular.
ZA200702322B (en) Compositions and methods for the diagnosis and treatment of tumor
GB0119011D0 (en) Treatment of nail infections
TW200744623A (en) Compositions and methods for eliciting an immune response to escape mutants of targeted therapies
WO2001085196A3 (en) Cxcr4 antagonist treatment of hematopoietic cells
WO2002083879A3 (en) Immunotherapy based on dendritic cells
TN2009000380A1 (en) Novel human anti-r7v antibodies and uses thereof
MX2009008580A (es) Composiciones lubricantes personales complementarias y sistema de administracion.
MY131964A (en) 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
UA94056C2 (uk) Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій
NZ602515A (en) Proteins that bind pi16 and uses thereof
GB0513556D0 (en) Product
AU2002349226A1 (en) Lactic acid bacteria and their use for treating and preventing cancer
WO2004024064A8 (en) Compositions and methods for the diagnosis and treatment of tumor
MX2007011381A (es) Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion.
IL177179A (en) Fusion protein comprising truncated n-acetylgalactosaminyltransferase 2 (galnact2) and maltose binding domain
MXPA03004539A (es) Luciferasas aisladas y uso de las mismas.
WO2023137381A3 (en) Bifidobacterium infantis formulations
AU2002235773A1 (en) Yeast strain for testing the geno- and cytotoxicity of complex environmental contamination
MXPA05008293A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181018